Filtros : "FCF004" "Löbenberg, Raimar" Limpar

Filtros



Refine with date range


  • Source: Nanomedicine. Unidades: FM, FCFRP, FCF

    Subjects: LEISHMANIA, SISTEMA LINFÁTICO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SOUZA, Aline de et al. Hydroxymethylnitrofurazone lymphatic uptake with nanostructured lipid carrier after oral administration in rats. Nanomedicine, v. 19, n. 4, p. 293-301, 2024Tradução . . Disponível em: https://dx.doi.org/10.2217/nnm-2023-0263. Acesso em: 09 set. 2024.
    • APA

      Souza, A. de, Scarim, C. B., Cotrim, P. C., Barbosa Junior, F., Rocha, B. A., Calixto, L. A., et al. (2024). Hydroxymethylnitrofurazone lymphatic uptake with nanostructured lipid carrier after oral administration in rats. Nanomedicine, 19( 4), 293-301. doi:10.2217/nnm-2023-0263
    • NLM

      Souza A de, Scarim CB, Cotrim PC, Barbosa Junior F, Rocha BA, Calixto LA, Correia C de J, Araujo GLB de, Löbenberg R, Bou-Chacra NA, Faloppa ACB. Hydroxymethylnitrofurazone lymphatic uptake with nanostructured lipid carrier after oral administration in rats [Internet]. Nanomedicine. 2024 ; 19( 4): 293-301.[citado 2024 set. 09 ] Available from: https://dx.doi.org/10.2217/nnm-2023-0263
    • Vancouver

      Souza A de, Scarim CB, Cotrim PC, Barbosa Junior F, Rocha BA, Calixto LA, Correia C de J, Araujo GLB de, Löbenberg R, Bou-Chacra NA, Faloppa ACB. Hydroxymethylnitrofurazone lymphatic uptake with nanostructured lipid carrier after oral administration in rats [Internet]. Nanomedicine. 2024 ; 19( 4): 293-301.[citado 2024 set. 09 ] Available from: https://dx.doi.org/10.2217/nnm-2023-0263
  • Source: Pharmaceutics. Unidade: FCF

    Subjects: FARMACOCINÉTICA, FARMACODINÂMICA

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      YOUSEF, Malaz et al. In vitro predictive model for intestinal lymphatic uptake: exploration of additional enhancers and inhibitors. Pharmaceutics, v. 16, n. 6 p. 1-13 art. 768, 2024Tradução . . Disponível em: https://dx.doi.org/10.3390/pharmaceutics16060768. Acesso em: 09 set. 2024.
    • APA

      Yousef, M., O’Croinin, C., Le, T. S., Park, C., Zuo, J., Bou-Chacra, N. A., et al. (2024). In vitro predictive model for intestinal lymphatic uptake: exploration of additional enhancers and inhibitors. Pharmaceutics, 16( 6 p. 1-13 art. 768). doi:10.3390/pharmaceutics16060768
    • NLM

      Yousef M, O’Croinin C, Le TS, Park C, Zuo J, Bou-Chacra NA, Davies NM, Löbenberg R. In vitro predictive model for intestinal lymphatic uptake: exploration of additional enhancers and inhibitors [Internet]. Pharmaceutics. 2024 ; 16( 6 p. 1-13 art. 768):[citado 2024 set. 09 ] Available from: https://dx.doi.org/10.3390/pharmaceutics16060768
    • Vancouver

      Yousef M, O’Croinin C, Le TS, Park C, Zuo J, Bou-Chacra NA, Davies NM, Löbenberg R. In vitro predictive model for intestinal lymphatic uptake: exploration of additional enhancers and inhibitors [Internet]. Pharmaceutics. 2024 ; 16( 6 p. 1-13 art. 768):[citado 2024 set. 09 ] Available from: https://dx.doi.org/10.3390/pharmaceutics16060768
  • Source: Journal of Drug Delivery Science and Technology. Unidade: FCF

    Subjects: DEPRESSÃO, MEDICAMENTO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      RICHTER, Luca Maurice et al. Assessing the utility of in silico tools in early drug development: The case of a pharmaceutically relevant formulation of the prodrug psilocybin. Journal of Drug Delivery Science and Technology, v. 92, p. 1-14, 2024Tradução . . Disponível em: https://dx.doi.org/10.1016/j.jddst.2023.105305. Acesso em: 09 set. 2024.
    • APA

      Richter, L. M., Al-Gousous, J., Araujo, G. L. B. de, Davies, N. M., & Löbenberg, R. (2024). Assessing the utility of in silico tools in early drug development: The case of a pharmaceutically relevant formulation of the prodrug psilocybin. Journal of Drug Delivery Science and Technology, 92, 1-14. doi:10.1016/j.jddst.2023.105305
    • NLM

      Richter LM, Al-Gousous J, Araujo GLB de, Davies NM, Löbenberg R. Assessing the utility of in silico tools in early drug development: The case of a pharmaceutically relevant formulation of the prodrug psilocybin [Internet]. Journal of Drug Delivery Science and Technology. 2024 ; 92 1-14.[citado 2024 set. 09 ] Available from: https://dx.doi.org/10.1016/j.jddst.2023.105305
    • Vancouver

      Richter LM, Al-Gousous J, Araujo GLB de, Davies NM, Löbenberg R. Assessing the utility of in silico tools in early drug development: The case of a pharmaceutically relevant formulation of the prodrug psilocybin [Internet]. Journal of Drug Delivery Science and Technology. 2024 ; 92 1-14.[citado 2024 set. 09 ] Available from: https://dx.doi.org/10.1016/j.jddst.2023.105305
  • Source: International Journal of Pharmaceutics. Unidade: FCF

    Subjects: FÁRMACOS, ANTI-HELMÍNTICOS

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      YUKUYAMA, Megumi Nishitani et al. Biphasic dissolution combined with modified cylinder method—A new promising method for dissolution test in drug-loaded nanoemulsions. International Journal of Pharmaceutics, v. 632, p. 1-9 art. 122554, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.ijpharm.2022.122554. Acesso em: 09 set. 2024.
    • APA

      Yukuyama, M. N., Zuo, J., Park, C., Yousef, M., Henostroza, M. A. B., Araujo, G. L. B. de, et al. (2023). Biphasic dissolution combined with modified cylinder method—A new promising method for dissolution test in drug-loaded nanoemulsions. International Journal of Pharmaceutics, 632, 1-9 art. 122554. doi:10.1016/j.ijpharm.2022.122554
    • NLM

      Yukuyama MN, Zuo J, Park C, Yousef M, Henostroza MAB, Araujo GLB de, Bou-Chacra NA, Löbenberg R. Biphasic dissolution combined with modified cylinder method—A new promising method for dissolution test in drug-loaded nanoemulsions [Internet]. International Journal of Pharmaceutics. 2023 ; 632 1-9 art. 122554.[citado 2024 set. 09 ] Available from: https://doi.org/10.1016/j.ijpharm.2022.122554
    • Vancouver

      Yukuyama MN, Zuo J, Park C, Yousef M, Henostroza MAB, Araujo GLB de, Bou-Chacra NA, Löbenberg R. Biphasic dissolution combined with modified cylinder method—A new promising method for dissolution test in drug-loaded nanoemulsions [Internet]. International Journal of Pharmaceutics. 2023 ; 632 1-9 art. 122554.[citado 2024 set. 09 ] Available from: https://doi.org/10.1016/j.ijpharm.2022.122554
  • Source: Research in Pharmaceutical Sciences. Unidade: FCF

    Subjects: LISOSSOMOS, MEDICAMENTO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      YOUSEF, Malaz et al. Sub-cellular sequestration of alkaline drugs in lysosomes: new insights for pharmaceutical development of lysosomal fluid. Research in Pharmaceutical Sciences, v. 18, n. 1, p. 1-15, 2023Tradução . . Disponível em: https://doi.org/10.4103/1735-5362.363591. Acesso em: 09 set. 2024.
    • APA

      Yousef, M., Le, T. S., Zuo, J., Park, C., Bou-Chacra, N. A., Davies, N. M., & Löbenberg, R. (2023). Sub-cellular sequestration of alkaline drugs in lysosomes: new insights for pharmaceutical development of lysosomal fluid. Research in Pharmaceutical Sciences, 18( 1), 1-15. doi:10.4103/1735-5362.363591
    • NLM

      Yousef M, Le TS, Zuo J, Park C, Bou-Chacra NA, Davies NM, Löbenberg R. Sub-cellular sequestration of alkaline drugs in lysosomes: new insights for pharmaceutical development of lysosomal fluid [Internet]. Research in Pharmaceutical Sciences. 2023 ; 18( 1): 1-15.[citado 2024 set. 09 ] Available from: https://doi.org/10.4103/1735-5362.363591
    • Vancouver

      Yousef M, Le TS, Zuo J, Park C, Bou-Chacra NA, Davies NM, Löbenberg R. Sub-cellular sequestration of alkaline drugs in lysosomes: new insights for pharmaceutical development of lysosomal fluid [Internet]. Research in Pharmaceutical Sciences. 2023 ; 18( 1): 1-15.[citado 2024 set. 09 ] Available from: https://doi.org/10.4103/1735-5362.363591
  • Source: Pharmaceutics. Unidade: FCF

    Subjects: SISTEMA LINFÁTICO, MEDICAMENTO

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      YOUSEF, Malaz et al. Development of a novel in vitro model to study lymphatic uptake of drugs via artificial chylomicrons. Pharmaceutics, v. 2, p. 1-17 art. 2532, 2023Tradução . . Disponível em: https://dx.doi.org/10.3390/pharmaceutics15112532. Acesso em: 09 set. 2024.
    • APA

      Yousef, M., Park, C., Henostroza, M., Bou-Chacra, N. A., Davies, N. M., & Löbenberg, R. (2023). Development of a novel in vitro model to study lymphatic uptake of drugs via artificial chylomicrons. Pharmaceutics, 2, 1-17 art. 2532. doi:10.3390/pharmaceutics15112532
    • NLM

      Yousef M, Park C, Henostroza M, Bou-Chacra NA, Davies NM, Löbenberg R. Development of a novel in vitro model to study lymphatic uptake of drugs via artificial chylomicrons [Internet]. Pharmaceutics. 2023 ; 2 1-17 art. 2532.[citado 2024 set. 09 ] Available from: https://dx.doi.org/10.3390/pharmaceutics15112532
    • Vancouver

      Yousef M, Park C, Henostroza M, Bou-Chacra NA, Davies NM, Löbenberg R. Development of a novel in vitro model to study lymphatic uptake of drugs via artificial chylomicrons [Internet]. Pharmaceutics. 2023 ; 2 1-17 art. 2532.[citado 2024 set. 09 ] Available from: https://dx.doi.org/10.3390/pharmaceutics15112532
  • Source: Journal of Drug Delivery Science and Technology. Unidades: FCF, ESALQ, IQ

    Subjects: ANTINEOPLÁSICOS, MICROTÚBULOS, NANOTECNOLOGIA, NEOPLASIAS PULMONARES

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      YUKUYAMA, Megumi Nishitani et al. Unveiling microtubule dynamics in lung cancer: recent findings and prospects for drug delivery and treatment. Journal of Drug Delivery Science and Technology, v. 89, p. 1-14 art. 105017, 2023Tradução . . Disponível em: https://dx.doi.org/10.1016/j.jddst.2023.105017. Acesso em: 09 set. 2024.
    • APA

      Yukuyama, M. N., Souza, A. de, Henostroza, M. A. B., Araujo, G. L. B. de, Löbenberg, R., Faria, R. de O., et al. (2023). Unveiling microtubule dynamics in lung cancer: recent findings and prospects for drug delivery and treatment. Journal of Drug Delivery Science and Technology, 89, 1-14 art. 105017. doi:10.1016/j.jddst.2023.105017
    • NLM

      Yukuyama MN, Souza A de, Henostroza MAB, Araujo GLB de, Löbenberg R, Faria R de O, Souza GB de, Guimarães LMF, Lameu C, Folchini BR, Peroni CM, Oliveira IF de, Miyagi MYS, Bou-Chacra NA. Unveiling microtubule dynamics in lung cancer: recent findings and prospects for drug delivery and treatment [Internet]. Journal of Drug Delivery Science and Technology. 2023 ; 89 1-14 art. 105017.[citado 2024 set. 09 ] Available from: https://dx.doi.org/10.1016/j.jddst.2023.105017
    • Vancouver

      Yukuyama MN, Souza A de, Henostroza MAB, Araujo GLB de, Löbenberg R, Faria R de O, Souza GB de, Guimarães LMF, Lameu C, Folchini BR, Peroni CM, Oliveira IF de, Miyagi MYS, Bou-Chacra NA. Unveiling microtubule dynamics in lung cancer: recent findings and prospects for drug delivery and treatment [Internet]. Journal of Drug Delivery Science and Technology. 2023 ; 89 1-14 art. 105017.[citado 2024 set. 09 ] Available from: https://dx.doi.org/10.1016/j.jddst.2023.105017
  • Source: Applied Chemical Engineering. Unidade: FCF

    Subjects: LIPOPROTEÍNAS, SISTEMA LINFÁTICO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      YOUSEF, Malaz et al. Lipoproteins within the lymphatic system: Insights into health, disease, and therapeutic implications. Applied Chemical Engineering, v. 6, n. 2, p. 1-7, 2023Tradução . . Disponível em: https://doi.org/10.24294/ace.v6i2.2202. Acesso em: 09 set. 2024.
    • APA

      Yousef, M., Bou-Chacra, N. A., Davies, N. M., & Löbenberg, R. (2023). Lipoproteins within the lymphatic system: Insights into health, disease, and therapeutic implications. Applied Chemical Engineering, 6( 2), 1-7. doi:10.24294/ace.v6i2.2202
    • NLM

      Yousef M, Bou-Chacra NA, Davies NM, Löbenberg R. Lipoproteins within the lymphatic system: Insights into health, disease, and therapeutic implications [Internet]. Applied Chemical Engineering. 2023 ; 6( 2): 1-7.[citado 2024 set. 09 ] Available from: https://doi.org/10.24294/ace.v6i2.2202
    • Vancouver

      Yousef M, Bou-Chacra NA, Davies NM, Löbenberg R. Lipoproteins within the lymphatic system: Insights into health, disease, and therapeutic implications [Internet]. Applied Chemical Engineering. 2023 ; 6( 2): 1-7.[citado 2024 set. 09 ] Available from: https://doi.org/10.24294/ace.v6i2.2202
  • Source: AAPS PharmSciTech. Unidade: FCF

    Subjects: ANTI-INFLAMATÓRIOS, FÁRMACOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      HAJJAR, Braa et al. In vitro evaluation of a foamable microemulsion towards an improved topical delivery of diclofenac sodium. AAPS PharmSciTech, v. 23, p. 1-9 art. 102, 2022Tradução . . Disponível em: https://doi.org/10.1208/s12249-022-02258-0. Acesso em: 09 set. 2024.
    • APA

      Hajjar, B., Zuo, J., Park, C., Azarmi, S., Silva, D. A., Bou-Chacra, N. A., & Löbenberg, R. (2022). In vitro evaluation of a foamable microemulsion towards an improved topical delivery of diclofenac sodium. AAPS PharmSciTech, 23, 1-9 art. 102. doi:10.1208/s12249-022-02258-0
    • NLM

      Hajjar B, Zuo J, Park C, Azarmi S, Silva DA, Bou-Chacra NA, Löbenberg R. In vitro evaluation of a foamable microemulsion towards an improved topical delivery of diclofenac sodium [Internet]. AAPS PharmSciTech. 2022 ; 23 1-9 art. 102.[citado 2024 set. 09 ] Available from: https://doi.org/10.1208/s12249-022-02258-0
    • Vancouver

      Hajjar B, Zuo J, Park C, Azarmi S, Silva DA, Bou-Chacra NA, Löbenberg R. In vitro evaluation of a foamable microemulsion towards an improved topical delivery of diclofenac sodium [Internet]. AAPS PharmSciTech. 2022 ; 23 1-9 art. 102.[citado 2024 set. 09 ] Available from: https://doi.org/10.1208/s12249-022-02258-0
  • Source: Dissolutiom Technologies. Unidade: FCF

    Subjects: FÁRMACOS, SISTEMA LINFÁTICO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      YOUSEF, Malaz et al. Simulated lymphatic fluid for in-vitro assessment in pharmaceutical development. Dissolutiom Technologies, v. 29, n. 2, p. 86-93, 2022Tradução . . Disponível em: https://doi.org/10.14227/DT290222P86. Acesso em: 09 set. 2024.
    • APA

      Yousef, M., Park, C., Le, T. S., Bou-Chacra, N. A., Davies, N. M., & Löbenberg, R. (2022). Simulated lymphatic fluid for in-vitro assessment in pharmaceutical development. Dissolutiom Technologies, 29( 2), 86-93. doi:10.14227/DT290222P86
    • NLM

      Yousef M, Park C, Le TS, Bou-Chacra NA, Davies NM, Löbenberg R. Simulated lymphatic fluid for in-vitro assessment in pharmaceutical development [Internet]. Dissolutiom Technologies. 2022 ; 29( 2): 86-93.[citado 2024 set. 09 ] Available from: https://doi.org/10.14227/DT290222P86
    • Vancouver

      Yousef M, Park C, Le TS, Bou-Chacra NA, Davies NM, Löbenberg R. Simulated lymphatic fluid for in-vitro assessment in pharmaceutical development [Internet]. Dissolutiom Technologies. 2022 ; 29( 2): 86-93.[citado 2024 set. 09 ] Available from: https://doi.org/10.14227/DT290222P86
  • Source: International Journal of Pharmaceutics. Unidade: FCF

    Subjects: LIPÍDEOS, ANTIBIÓTICOS, INFECÇÕES BACTERIANAS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      HENOSTROZA, Mirla Anali Bazán et al. Antibiotic-loaded lipid-based nanocarrier: a promising strategy to overcome bacterial infection. International Journal of Pharmaceutics, v. 621 , p. 1-15 art.121782, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.ijpharm.2022.121782. Acesso em: 09 set. 2024.
    • APA

      Henostroza, M. A. B., Tavares, G. D., Yukuyama, M. N., Souza, A. de, Barbosa, E. J., Avino, V. C., et al. (2022). Antibiotic-loaded lipid-based nanocarrier: a promising strategy to overcome bacterial infection. International Journal of Pharmaceutics, 621 , 1-15 art.121782. doi:10.1016/j.ijpharm.2022.121782
    • NLM

      Henostroza MAB, Tavares GD, Yukuyama MN, Souza A de, Barbosa EJ, Avino VC, Santos Neto E dos, Lourenço FR, Löbenberg R, Bou-Chacra NA. Antibiotic-loaded lipid-based nanocarrier: a promising strategy to overcome bacterial infection [Internet]. International Journal of Pharmaceutics. 2022 ; 621 1-15 art.121782.[citado 2024 set. 09 ] Available from: https://doi.org/10.1016/j.ijpharm.2022.121782
    • Vancouver

      Henostroza MAB, Tavares GD, Yukuyama MN, Souza A de, Barbosa EJ, Avino VC, Santos Neto E dos, Lourenço FR, Löbenberg R, Bou-Chacra NA. Antibiotic-loaded lipid-based nanocarrier: a promising strategy to overcome bacterial infection [Internet]. International Journal of Pharmaceutics. 2022 ; 621 1-15 art.121782.[citado 2024 set. 09 ] Available from: https://doi.org/10.1016/j.ijpharm.2022.121782
  • Source: Dissolution Technologies. Unidade: FCF

    Subjects: TRATO GASTROINTESTINAL, FARMACOCINÉTICA, MEDICAMENTO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SILVA, Daniela Amaral et al. Update on gastrointestinal biorelevant media and physiologically relevant dissolution conditions. Dissolution Technologies, v. 29, n. 2, p. 62-75, 2022Tradução . . Disponível em: https://doi.org/10.14227/DT290222P62. Acesso em: 09 set. 2024.
    • APA

      Silva, D. A., Davies, N. M., Bou-Chacra, N. A., Ferraz, H. G., & Löbenberg, R. (2022). Update on gastrointestinal biorelevant media and physiologically relevant dissolution conditions. Dissolution Technologies, 29( 2), 62-75. doi:10.14227/DT290222P62
    • NLM

      Silva DA, Davies NM, Bou-Chacra NA, Ferraz HG, Löbenberg R. Update on gastrointestinal biorelevant media and physiologically relevant dissolution conditions [Internet]. Dissolution Technologies. 2022 ; 29( 2): 62-75.[citado 2024 set. 09 ] Available from: https://doi.org/10.14227/DT290222P62
    • Vancouver

      Silva DA, Davies NM, Bou-Chacra NA, Ferraz HG, Löbenberg R. Update on gastrointestinal biorelevant media and physiologically relevant dissolution conditions [Internet]. Dissolution Technologies. 2022 ; 29( 2): 62-75.[citado 2024 set. 09 ] Available from: https://doi.org/10.14227/DT290222P62
  • Source: Abstracts. Conference titles: Research Day Equity in Health and Research. Unidade: FCF

    Subjects: FÁRMACOS, XENOBIÓTICO

    Acesso à fonteHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      YOUSEF, Malaz et al. In-vitro model to forecast the lymphatic uptake/inhibition of drugs via chylomicrons. 2022, Anais.. Alberta: University of Alberta, 2022. Disponível em: https://www.cspscanada.org/wp-content/uploads/CSPS-2022-Malaz-Yousef.pdf. Acesso em: 09 set. 2024.
    • APA

      Yousef, M., Bou-Chacra, N. A., Davies, N. M., & Löbenberg, R. (2022). In-vitro model to forecast the lymphatic uptake/inhibition of drugs via chylomicrons. In Abstracts. Alberta: University of Alberta. Recuperado de https://www.cspscanada.org/wp-content/uploads/CSPS-2022-Malaz-Yousef.pdf
    • NLM

      Yousef M, Bou-Chacra NA, Davies NM, Löbenberg R. In-vitro model to forecast the lymphatic uptake/inhibition of drugs via chylomicrons [Internet]. Abstracts. 2022 ;[citado 2024 set. 09 ] Available from: https://www.cspscanada.org/wp-content/uploads/CSPS-2022-Malaz-Yousef.pdf
    • Vancouver

      Yousef M, Bou-Chacra NA, Davies NM, Löbenberg R. In-vitro model to forecast the lymphatic uptake/inhibition of drugs via chylomicrons [Internet]. Abstracts. 2022 ;[citado 2024 set. 09 ] Available from: https://www.cspscanada.org/wp-content/uploads/CSPS-2022-Malaz-Yousef.pdf
  • Source: Abstracts. Conference titles: Research Day Equity in Health and Research. Unidade: FCF

    Assunto: FÁRMACOS

    Acesso à fonteHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      HAJJAR, Braa et al. In vitro study of a foamable microemulsion for improved topical delivery of diclofenac sodium. 2022, Anais.. Alberta: University of Alberta, 2022. Disponível em: https://www.cspscanada.org/wp-content/uploads/CSPS-2022-Zuo-poster.pdf. Acesso em: 09 set. 2024.
    • APA

      Hajjar, B., Zuo, J., Azami, S., Silva, D. A., Bou-Chacra, N. A., & Löbenberg, R. (2022). In vitro study of a foamable microemulsion for improved topical delivery of diclofenac sodium. In Abstracts. Alberta: University of Alberta. Recuperado de https://www.cspscanada.org/wp-content/uploads/CSPS-2022-Zuo-poster.pdf
    • NLM

      Hajjar B, Zuo J, Azami S, Silva DA, Bou-Chacra NA, Löbenberg R. In vitro study of a foamable microemulsion for improved topical delivery of diclofenac sodium [Internet]. Abstracts. 2022 ;[citado 2024 set. 09 ] Available from: https://www.cspscanada.org/wp-content/uploads/CSPS-2022-Zuo-poster.pdf
    • Vancouver

      Hajjar B, Zuo J, Azami S, Silva DA, Bou-Chacra NA, Löbenberg R. In vitro study of a foamable microemulsion for improved topical delivery of diclofenac sodium [Internet]. Abstracts. 2022 ;[citado 2024 set. 09 ] Available from: https://www.cspscanada.org/wp-content/uploads/CSPS-2022-Zuo-poster.pdf
  • Source: Journal of Pharmacy & Pharmaceutical Sciences. Unidade: FCF

    Subjects: SISTEMA LINFÁTICO, FISIOLOGIA

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      YOUSEF, Malaz et al. The lymphatic system: a sometimes-forgotten compartment in pharmaceutical sciences. Journal of Pharmacy & Pharmaceutical Sciences, v. 24, p. 533-547, 2021Tradução . . Disponível em: https://doi.org/10.18433/jpps32222. Acesso em: 09 set. 2024.
    • APA

      Yousef, M., Silva, D. A., Bou-Chacra, N. A., Davies, N. M., & Löbenberg, R. (2021). The lymphatic system: a sometimes-forgotten compartment in pharmaceutical sciences. Journal of Pharmacy & Pharmaceutical Sciences, 24, 533-547. doi:10.18433/jpps32222
    • NLM

      Yousef M, Silva DA, Bou-Chacra NA, Davies NM, Löbenberg R. The lymphatic system: a sometimes-forgotten compartment in pharmaceutical sciences [Internet]. Journal of Pharmacy & Pharmaceutical Sciences. 2021 ; 24 533-547.[citado 2024 set. 09 ] Available from: https://doi.org/10.18433/jpps32222
    • Vancouver

      Yousef M, Silva DA, Bou-Chacra NA, Davies NM, Löbenberg R. The lymphatic system: a sometimes-forgotten compartment in pharmaceutical sciences [Internet]. Journal of Pharmacy & Pharmaceutical Sciences. 2021 ; 24 533-547.[citado 2024 set. 09 ] Available from: https://doi.org/10.18433/jpps32222
  • Source: Pharmaceutical Research. Unidade: FCF

    Subjects: MEDICINA ALTERNATIVA, FITOTERAPIA, PRODUTOS NATURAIS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ZUO, Jieyu et al. Traditional chinese medicine “Pill”, an ancient dosage Form with surprising modern pharmaceutical characteristics. Pharmaceutical Research, v. 38, n. 2, p. 199-211, 2021Tradução . . Disponível em: https://doi.org/10.1007/s11095-021-03007-x. Acesso em: 09 set. 2024.
    • APA

      Zuo, J., Park, C., Kung, J. Y. C., Bou-Chacra, N. A., Doschak, M., & Löbenberg, R. (2021). Traditional chinese medicine “Pill”, an ancient dosage Form with surprising modern pharmaceutical characteristics. Pharmaceutical Research, 38( 2), 199-211. doi:10.1007/s11095-021-03007-x
    • NLM

      Zuo J, Park C, Kung JYC, Bou-Chacra NA, Doschak M, Löbenberg R. Traditional chinese medicine “Pill”, an ancient dosage Form with surprising modern pharmaceutical characteristics [Internet]. Pharmaceutical Research. 2021 ; 38( 2): 199-211.[citado 2024 set. 09 ] Available from: https://doi.org/10.1007/s11095-021-03007-x
    • Vancouver

      Zuo J, Park C, Kung JYC, Bou-Chacra NA, Doschak M, Löbenberg R. Traditional chinese medicine “Pill”, an ancient dosage Form with surprising modern pharmaceutical characteristics [Internet]. Pharmaceutical Research. 2021 ; 38( 2): 199-211.[citado 2024 set. 09 ] Available from: https://doi.org/10.1007/s11095-021-03007-x
  • Source: Journal of Pharmaceutical Innovation. Unidades: FCF, EACH

    Subjects: INFECÇÕES OCULARES, PSEUDOMONAS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ROCHA, Emmily Dantas et al. Enhanced In vitro antimicrobial activity of polymyxin B–Coated nanostructured lipid carrier containing dexamethasone acetate. Journal of Pharmaceutical Innovation, v. 16, n. 1, p. 125–135, 2021Tradução . . Disponível em: https://doi.org/10.1007/s12247-020-09427-3. Acesso em: 09 set. 2024.
    • APA

      Rocha, E. D., Ferreira, M. R. S., Santos Neto, E. dos, Barbosa, E. J., Löbenberg, R., Lourenço, F. R., & Bou-Chacra, N. A. (2021). Enhanced In vitro antimicrobial activity of polymyxin B–Coated nanostructured lipid carrier containing dexamethasone acetate. Journal of Pharmaceutical Innovation, 16( 1), 125–135. doi:10.1007/s12247-020-09427-3
    • NLM

      Rocha ED, Ferreira MRS, Santos Neto E dos, Barbosa EJ, Löbenberg R, Lourenço FR, Bou-Chacra NA. Enhanced In vitro antimicrobial activity of polymyxin B–Coated nanostructured lipid carrier containing dexamethasone acetate [Internet]. Journal of Pharmaceutical Innovation. 2021 ; 16( 1): 125–135.[citado 2024 set. 09 ] Available from: https://doi.org/10.1007/s12247-020-09427-3
    • Vancouver

      Rocha ED, Ferreira MRS, Santos Neto E dos, Barbosa EJ, Löbenberg R, Lourenço FR, Bou-Chacra NA. Enhanced In vitro antimicrobial activity of polymyxin B–Coated nanostructured lipid carrier containing dexamethasone acetate [Internet]. Journal of Pharmaceutical Innovation. 2021 ; 16( 1): 125–135.[citado 2024 set. 09 ] Available from: https://doi.org/10.1007/s12247-020-09427-3
  • Source: Future Medicinal Chemistry. Unidade: FCF

    Subjects: DOENÇAS RESPIRATÓRIAS, FARMACOCINÉTICA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      PRASHER, Parteek et al. Advanced drug delivery systems targeting NF-κB in respiratory diseases. Future Medicinal Chemistry, v. 13, n. 13, p. 1087-1090, 2021Tradução . . Disponível em: https://doi.org/10.4155/fmc-2021-0013. Acesso em: 09 set. 2024.
    • APA

      Prasher, P., Sharma, M., Chellappan, D. K., Gupta, G., Jha, N. K., Singh, S. K., et al. (2021). Advanced drug delivery systems targeting NF-κB in respiratory diseases. Future Medicinal Chemistry, 13( 13), 1087-1090. doi:10.4155/fmc-2021-0013
    • NLM

      Prasher P, Sharma M, Chellappan DK, Gupta G, Jha NK, Singh SK, MacLoughlin R, Pinto T de JA, Löbenberg R, Dua K. Advanced drug delivery systems targeting NF-κB in respiratory diseases [Internet]. Future Medicinal Chemistry. 2021 ; 13( 13): 1087-1090.[citado 2024 set. 09 ] Available from: https://doi.org/10.4155/fmc-2021-0013
    • Vancouver

      Prasher P, Sharma M, Chellappan DK, Gupta G, Jha NK, Singh SK, MacLoughlin R, Pinto T de JA, Löbenberg R, Dua K. Advanced drug delivery systems targeting NF-κB in respiratory diseases [Internet]. Future Medicinal Chemistry. 2021 ; 13( 13): 1087-1090.[citado 2024 set. 09 ] Available from: https://doi.org/10.4155/fmc-2021-0013
  • Source: Colloids and Surfaces A. Unidades: ICB, FCF

    Subjects: MENINGITE, ANTIFÚNGICOS, PLANEJAMENTO DE FÁRMACOS, CRIPTOCOCOSE, EMULSÕES (FORMAS FARMACÊUTICAS), CAMUNDONGOS, MODELOS ANIMAIS DE DOENÇAS, MICROBIOLOGIA

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      YUKUYAMA, Megumi Nishitani et al. Rational design of oral flubendazole-loaded nanoemulsion for brain delivery in Cryptococcosis. Colloids and Surfaces A, v. 630, p. 1-10 art. 127631, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.colsurfa.2021.127631. Acesso em: 09 set. 2024.
    • APA

      Yukuyama, M. N., Ishida, K., Araujo, G. L. B. de, Spadari, C. de C., Souza, A. de, Löbenberg, R., et al. (2021). Rational design of oral flubendazole-loaded nanoemulsion for brain delivery in Cryptococcosis. Colloids and Surfaces A, 630, 1-10 art. 127631. doi:10.1016/j.colsurfa.2021.127631
    • NLM

      Yukuyama MN, Ishida K, Araujo GLB de, Spadari C de C, Souza A de, Löbenberg R, Henostroza MAB, Folchini BR, Peroni CM, Peters MCC, Oliveira IF de, Miyagi MYS, Bou-Chacra NA. Rational design of oral flubendazole-loaded nanoemulsion for brain delivery in Cryptococcosis [Internet]. Colloids and Surfaces A. 2021 ; 630 1-10 art. 127631.[citado 2024 set. 09 ] Available from: https://doi.org/10.1016/j.colsurfa.2021.127631
    • Vancouver

      Yukuyama MN, Ishida K, Araujo GLB de, Spadari C de C, Souza A de, Löbenberg R, Henostroza MAB, Folchini BR, Peroni CM, Peters MCC, Oliveira IF de, Miyagi MYS, Bou-Chacra NA. Rational design of oral flubendazole-loaded nanoemulsion for brain delivery in Cryptococcosis [Internet]. Colloids and Surfaces A. 2021 ; 630 1-10 art. 127631.[citado 2024 set. 09 ] Available from: https://doi.org/10.1016/j.colsurfa.2021.127631
  • Source: European Journal of Pharmaceutical Sciences. Unidade: FCF

    Subjects: ANTI-INFLAMATÓRIOS NÃO ESTEROIDES, NANOTECNOLOGIA

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MACEDO, Luiza Oliveira et al. Anti-inflammatory drug nanocrystals: state of art and regulatory perspective. European Journal of Pharmaceutical Sciences, v. 158, p. 1-15 art. 105654, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.ejps.2020.105654. Acesso em: 09 set. 2024.
    • APA

      Macedo, L. O., Barbosa, E. J., Löbenberg, R., & Bou-Chacra, N. A. (2021). Anti-inflammatory drug nanocrystals: state of art and regulatory perspective. European Journal of Pharmaceutical Sciences, 158, 1-15 art. 105654. doi:10.1016/j.ejps.2020.105654
    • NLM

      Macedo LO, Barbosa EJ, Löbenberg R, Bou-Chacra NA. Anti-inflammatory drug nanocrystals: state of art and regulatory perspective [Internet]. European Journal of Pharmaceutical Sciences. 2021 ; 158 1-15 art. 105654.[citado 2024 set. 09 ] Available from: https://doi.org/10.1016/j.ejps.2020.105654
    • Vancouver

      Macedo LO, Barbosa EJ, Löbenberg R, Bou-Chacra NA. Anti-inflammatory drug nanocrystals: state of art and regulatory perspective [Internet]. European Journal of Pharmaceutical Sciences. 2021 ; 158 1-15 art. 105654.[citado 2024 set. 09 ] Available from: https://doi.org/10.1016/j.ejps.2020.105654

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024